US Patent 7087224 Method of treating anemia by administering IL-1ra

Patent 7087224 was granted and assigned to Amgen on August, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7087224

Date of Patent

August 8, 2006

Patent Application Number

09969739

Date Filed

October 2, 2001

Patent Primary Examiner

‌

Prema Mertz

Patent abstract

The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.